givosiran sodium
givosiran sodium is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including GIVLAARI. Available dosage forms: injection, solution, powder.
Drug Details
- Generic Name
- givosiran sodium
- Brand Names
- GIVLAARI
- Application Number
- NDA212194
- Sponsor
- Alnylam Pharmaceuticals, Inc.
- NDC Codes
- 2
- Dosage Forms
- INJECTION, SOLUTION, POWDER
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GIVOSIRAN SODIUM, GIVOSIRAN
Indications and Usage
1 INDICATIONS AND USAGE GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP). GIVLAARI is an aminolevulinate synthase 1-directed small interfering RNA indicated for the treatment of adults with acute hepatic porphyria (AHP). ( 1 )